Skip to main content
Article
Chronic Kidney Disease (CKD) outcomes with dulglutide (DU) versus insulin glargine (IG) in type 2 diabetes and moderate-to-severe CKD by albuminuria status: AWARD-7.
AACE-GULF (2019) American Association of Clinical Endocrinologists - 7th Gulf Chapter Annual Meeting
  • Katherine Tuttle, Providence Sacred Heart Medical Center
  • Brian Rayner
  • Mark Lakshmanan
  • D. Bradley Woodward
  • Anita Kawn
  • Manige Konig
  • Fady Botros
Document Type
Abstract
Publication Date
10-1-2019
Clinical Institute
Kidney & Diabetes
Specialty
Endocrinology
Citation Information
Katherine Tuttle, Brian Rayner, Mark Lakshmanan, D. Bradley Woodward, et al.. "Chronic Kidney Disease (CKD) outcomes with dulglutide (DU) versus insulin glargine (IG) in type 2 diabetes and moderate-to-severe CKD by albuminuria status: AWARD-7." AACE-GULF (2019) American Association of Clinical Endocrinologists - 7th Gulf Chapter Annual Meeting (2019)
Available at: http://works.bepress.com/katherine-tuttle/186/